Abstract
Introduction Acute bronchitis is the most common disease of the bronchopulmonary apparatus, with an annual incidence rate of approximately 5% in adults and 10% in children. Clinical studies have shown that antibiotics provide limited benefits, and that the early use of immunomodulators improves the clinical course of bronchitis. The present study aimed to determine the therapeutic efficacy of Derinat in children and adolescents with acute bronchitis. Materials and methods
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
